Mitsubishi Tanabe Pharma issues its news to provide stakeholders with the latest information related to the Company. Information on products or drug candidates may be included, but is intended to provide for the media, etc. It is not intended for promotion, advertising or medical advice.
Information RADICAVA to treat ALS now available in U.S.
August 9, 2017
Mitsubishi Tanabe Pharma America Inc., a sales subsidiary of Mitsubishi Tanabe Pharma Corporation announced RADICAVA is now available in the United States.
Press Release[PDF:323KB](Aug. 8, 2017)